Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

The researchers repurposed the drug edaravone, an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe to be used with central nervous system PET imaging.

The researchers repurposed the drug edaravone, an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe to be used with central nervous system PET imaging. With this technique ...

An oral version of edaravone was cleared this year. Relyvrio takes the form of a powder that is mixed with water and can be taken via a feeding tube, and has been approved based on the phase 2 ...

Jude Children’s Research Hospital is enhancing the technique’s ability to check for signs of neurological disease. The researchers repurposed the drug edaravone, an antioxidant used to treat ...

Scientists at St. Jude Children’s Research Hospital used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress Positron emission tomography (PET ...

Mitsubishi Tanabe Pharma has withdrawn its EU application for ALS drug Radicava (edaravone), citing ‘unwarranted’ additional data requirements from the EMA. The drug has been approved in the ...